Search for a command to run...
Shree Ganesh Bio-Tech (India) Ltd. is currently lagging behind its peers in terms of profitability, growth, and valuation. The company shows no revenue growth or profitability metrics, making it less attractive compared to higher-performing peers. Companies like Kaveri Seed Company and Bombay Burmah Trading Corporation stand out as strong performers, demonstrating solid growth and profitability, while Shree Ganesh is a clear underperformer in the agriculture sector.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Shree Ganesh Bio-Tech (India) Ltd. | ₹0.75 | ₹29.90Cr | 62.50 | - | - |
BBTC | ₹1,786.90 | ₹12,467.54Cr | 104.55 | 46.17% | 0.27 |
KSCL | ₹1,187.60 | ₹6,108.91Cr | 23.03 | 21.77% | - |
JUBLCPL | ₹2,958.75 | ₹4,457.98Cr | 50.24 | 34.93% | 0.18 |
VENKEYS | ₹1,462.55 | ₹2,060.34Cr | 17.67 | 10.04% | 0.81 |
Regaal Resources Ltd. | ₹110.85 | ₹1,138.69Cr | 23.89 | - | - |
MGEL | ₹15.72 | ₹518.06Cr | 23.82 | 14.40% | 1.45 |